Integrative analysis confirms TPX2 as a novel biomarker for clinical implication - tumor microenvironment, and immunotherapy response across human solid tumors
Favorite
Share
More Options
Fullscreen
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
